Differential thermostability and response to cystic fibrosis transmembrane conductance regulator (CFTR) potentiators of human and mouse F508del-CFTR

Differential thermostability and response to cystic fibrosis transmembrane conductance regulator (CFTR) potentiators of human and mouse F508del-CFTR

Cross-species comparative studies have highlighted differences between human and mouse cystic fibrosis transmembrane conductance regulator (CFTR), the epithelial Cl− channel defective in cystic fibrosis (CF). Here, we compare the impact of the most common CF mutation F508del on the function of human...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Bose, S, Bijvelds, M, Wang, Y, Liu, J, Cai, Z, Bot, A, De Jonge, H, Sheppard, D
Natura:	Journal article
Lingua:	English
Pubblicazione:	American Physiological Society 2019

Documenti analoghi

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
di: Veselu, D-F, et al.
Pubblicazione: (2024)

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
di: Giuseppe Fabio Parisi, et al.
Pubblicazione: (2022-05-01)

Localization of the cystic fibrosis transmembrane conductance regulator (Cftr) to mouse chromosome 6.
di: Siegel, D, et al.
Pubblicazione: (1992)

The Cystic Fibrosis Transmembrane Regulator (CFTR) in the kidney
di: MARCELO M. MORALES, et al.
Pubblicazione: (2000-09-01)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
di: Ryosuke Fukuda, et al.
Pubblicazione: (2020-04-01)

Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice
di: Barbara Dhooghe, et al.
Pubblicazione: (2015-07-01)

Relating the disease mutation spectrum to the evolution of the cystic fibrosis transmembrane conductance regulator (CFTR).
di: Lavanya Rishishwar, et al.
Pubblicazione: (2012-01-01)

Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye
di: Meltem Akgül Erdal, et al.
Pubblicazione: (2025-02-01)

Production of CFTR-ΔF508 Rabbits
di: Dongshan Yang, et al.
Pubblicazione: (2021-01-01)

Ouabain mimics low temperature rescue of F508del-CFTR in cystic fibrosis epithelial cells
di: Donglei eZhang, et al.
Pubblicazione: (2012-10-01)

SFPQ rescues F508del-CFTR expression and function in cystic fibrosis bronchial epithelial cells
di: Parameet Kumar, et al.
Pubblicazione: (2021-08-01)

Characterization of nasal potential difference in cftr knockout and F508del-CFTR mice.
di: Emilie Lyne Saussereau, et al.
Pubblicazione: (2013-01-01)

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
di: Paulami Chatterjee, et al.
Pubblicazione: (2024-09-01)

Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
di: Stephanie Chin, et al.
Pubblicazione: (2019-07-01)

Bacterial Sphingomyelinase is a State-Dependent Inhibitor of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR)
di: B. B. Stauffer, et al.
Pubblicazione: (2017-06-01)

Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
di: Serena Schippa, et al.
Pubblicazione: (2013-01-01)

Successful Therapy over 12 Months of People with Cystic Fibrosis with Rare Non-phe508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations with Elexacaftor/Tezacaftor/Ivacaftor (ETI)
di: Tomke Sütering, et al.
Pubblicazione: (2024-12-01)

Rescue of murine F508del CFTR activity in native intestine by low temperature and proteasome inhibitors.
di: Martina Wilke, et al.
Pubblicazione: (2012-01-01)

Defective fluid secretion from submucosal glands of nasal turbinates from CFTR-/- and CFTR (ΔF508/ΔF508) pigs.
di: Hyung-Ju Cho, et al.
Pubblicazione: (2011-01-01)

Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients
Pubblicazione: (2013-01-01)

Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients.
di: Serena Schippa, et al.
Pubblicazione: (2013-01-01)

Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity.
di: Firhan A Malik, et al.
Pubblicazione: (2015-01-01)

Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
di: Issa Siryani, et al.
Pubblicazione: (2015-01-01)

The Inhibition of the Membrane-Bound Transcription Factor Site-1 Protease (MBTP1) Alleviates the p.Phe508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Defects in Cystic Fibrosis Cells
di: Raphaël Santinelli, et al.
Pubblicazione: (2024-01-01)

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
di: Jennifer L. Taylor-Cousar, et al.
Pubblicazione: (2019-06-01)

Characterization of two rat models of cystic fibrosis—KO and F508del CFTR—Generated by Crispr‐Cas9
di: Elise Dreano, et al.
Pubblicazione: (2019-12-01)

Integrative genomic meta-analysis reveals novel molecular insights into cystic fibrosis and ΔF508-CFTR rescue
di: Rachel A. Hodos, et al.
Pubblicazione: (2020-11-01)

Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats.
di: Katherine L Tuggle, et al.
Pubblicazione: (2014-01-01)

Analysis of mutations in the cystic fibrosis transmembrane regulator (CFTR) gene in patients with obstructive azoospermia
di: Andrea L.F. Bernardino, et al.
Pubblicazione: (2003-01-01)

'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
di: Knowles Michael R, et al.
Pubblicazione: (2001-08-01)

Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis.
di: Scott Mackenzie Brockman, et al.
Pubblicazione: (2017-01-01)

Targeting protein–protein interactions to rescue Δf508‐cftr: a novel corrector approach to treat cystic fibrosis
di: Isabel Devesa, et al.
Pubblicazione: (2013-08-01)

State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (<i>CFTR</i>) Modulators and Triple-Combination Therapy
di: Aniello Meoli, et al.
Pubblicazione: (2021-09-01)

Structural Comparative Modeling of Multi-Domain F508del CFTR
di: Eli Fritz McDonald, et al.
Pubblicazione: (2022-03-01)

Syntaxin 8 and the Endoplasmic Reticulum Processing of ΔF508-CFTR
di: Inna Sabirzhanova, et al.
Pubblicazione: (2018-11-01)

Genetic modification of cystic fibrosis with ΔF508 mutation of CFTR gene using the CRISPR system in peripheral blood mononuclear cells
di: Sepideh Khatibi, et al.
Pubblicazione: (2021-01-01)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
di: Evelina Moliteo, et al.
Pubblicazione: (2022-08-01)

CFTR and Ca2+ signaling in cystic fibrosis
di: Fabrice eAntigny, et al.
Pubblicazione: (2011-10-01)

Strategies to circumvent the CFTR defect in cystic fibrosis
di: Frederic eBecq, et al.
Pubblicazione: (2013-08-01)

Analysis of multiple gene co-expression networks to discover interactions favoring CFTR biogenesis and ΔF508-CFTR rescue
di: Matthew D. Strub, et al.
Pubblicazione: (2021-10-01)